Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Buy
2,647
+607
+30% +$71K 0.05% 248
2026
Q1
$245K Buy
+2,040
New +$236K 0.05% 260
2025
Q1
Sell
-10,608
Closed -$1.06M 261
2024
Q4
$1.06M Buy
10,608
+221
+2% +$22.8K 0.26% 124
2024
Q3
$1.09M Buy
10,387
+324
+3% +$38.5K 0.27% 116
2024
Q2
$1.25M Buy
10,063
+805
+9% +$104K 0.34% 91
2024
Q1
$1.21M Buy
9,258
+6,698
+262% +$826K 0.34% 90
2023
Q4
$279K Hold
2,560
0.08% 205
2023
Q3
$264K Buy
2,560
+34
+1% +$3.67K 0.09% 201
2023
Q2
$272K Sell
2,526
-60
-2% -$6.81K 0.08% 208
2023
Q1
$275K Hold
2,586
0.09% 208
2022
Q4
$273K Hold
2,586
0.09% 208
2022
Q3
$261K Buy
2,586
+159
+7% +$14.2K 0.1% 201
2022
Q2
$221K Hold
2,427
0.09% 209
2022
Q1
$211K Sell
2,427
-390
-14% -$30.7K 0.07% 232
2021
Q4
$216K Buy
+2,817
New +$224K 0.09% 207

Other funds holding MRK

Waterfront Wealth's MRK Position: Q2 2026 in Review

Waterfront Wealth increased its Merck (MRK) stake by 30% in Q2 2026, buying an estimated $71K and bringing the position to 2,647 shares worth $327K. The position accounts for 0.05% of the portfolio, ranked #248.

Waterfront Wealth first reported a position in MRK in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.25M in Q2 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Waterfront Wealth held 2,647 shares of Merck worth $327K as of Q2 2026.
  • Waterfront Wealth bought 607 Merck shares in Q2 2026, an estimated $71K.
  • Merck made up 0.05% of Waterfront Wealth's portfolio in Q2 2026, its #248 holding.
  • Waterfront Wealth first reported a position in Merck in Q4 2021 and has held it in 15 quarters since.
  • Waterfront Wealth's Merck position peaked at $1.25M in Q2 2024.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.